Pfizer, Inc. · NYSE:PFE
Pfizer — First Fridays Webinar Series (October 2010)
20 slides from Pfizer's conference presentation, Oct 1, 2010
Slide 1: First Fridays Webinar Series: Medical Education Group (MEG)
10/18/2010 First Fridays Webinar Series: Medical Education Group (MEG) October 1st, 2010 1 Series Goals (5) 1. To provide insights into how Pfizer’s Medical Education Group (MEG) functions – an operational overview 2. To share an up-to-date status of Pfizer’s MEG timelines and grant review cycles 3.
Slide 2: Agenda and Today's Objectives
10/18/2010 Agenda 1. Introduction 2. Topic One: Rationale for Grant Denial 3. Topic Two: Best Practices from Northern Michigan 4 Q and A 4. 3 Today’s Objectives (3) Upon completion of today’s call, participants should be able to: 1. Describe how the processes of MEG are designed to support the Missi
Slide 3: Who is MEG? Mission, Vision, and Goals
10/18/2010 Who is MEG? MEG Strategy MEG Operations Maureen Doyle-Scharff, MBA, FACME Ericka Eda, MBA, CPA Senior Director, Team Lead Director, Team Lead Susan Connelly, PharmD, MBA Christine Perri Education Director, Specialty Grant Manager, Specialty Robert E. Kristofco, MSW, FACME Laura Bartolomeo
Slide 4: Why Does MEG exist? The MEG 2-Step: Overview
10/18/2010 Why Does MEG exist? • MEG exists to provide educational grant support to the medical communityy in a compliant p and effective manner • Effective education accelerates the adoption curve of evidence-based clinical skills and practices • By funding good education, commercial support improv
Slide 5: Q4 Timeline
10/18/2010 MEG Web Portal: www.pfizermededgrants.com 9 Q4 Timeline • September 1st grant request window opened ~ 6 wks • O t b 15th grantt requestt window October i d closed l d • October 16th GMs begin to triage and review – Compliance, alignment, & completeness ~ 8 days – Routing pathways are esta
Slide 6: Summary of MEG Process; Rationale for Grant Denial
10/18/2010 Summary of MEG Process • Q4 grant request window is open • The competitive, p , batched p process simplified p the submission and review process, ensuring that the best proposals are funded • The vast majority of funding is provided to smaller requests addressing smaller, more-defined, le
Slide 7: Form Letters; Only 30%
10/18/2010 Form Letters • Automatic communications are generated for all declined requests – “Thank Thank you for your application to the Pfizer Medical Education Group. We appreciate the effort that it takes to apply for grants. After careful consideration, we regret to inform you that we are unabl
Slide 8: Reasons for Denial; Promotional Speakers
10/18/2010 Reasons for Denial Scope Promotional Speakers Ranking Alignment Funding Date of event Process & Competitive Compliance Policy Review Issues Eligibility Requestor Withdrawal Previous outcomes Incomplete applications 15 Promotional Speakers • Primary reason for denial – Your request include
Slide 9: Date of Event; Funding
10/18/2010 Date of Event • Primary reason for denial – it was submitted outside our quarterly grant window timelines. The application pp p periods and corresponding p g decision dates can be found on our website. Please refer to the FAQ section on our website for grant review cycle details • Quarter
Slide 10: Scope; Eligibility
10/18/2010 Scope • Primary reason for denial – it does not meet the criteria for an independent medical education ggrant. Please refer to the log-in g page of our website for definitions of other types of requests such as sponsorships, fellowships, charitable healthcare contributions, special events
Slide 11: Incomplete Applications; Compliance
10/18/2010 Incomplete applications • Primary reason for denial – your request was incomplete. We contacted you to obtain the missing g information;; however,, we did not receive a response. Process & Policy Issues 21 Compliance • Primary reason for denial – the program you proposed is in violation o
Slide 12: Requestor Withdrawal; Alignment
10/18/2010 Requestor Withdrawal • Primary reason for denial – your grant submission was withdrawn per your request. q Process & Policy Issues 23 Alignment • Primary reason for denial – the program you proposed is not currently as strongly aligned with our educational focus as other grants we have ch
Slide 13: Ranking; Grant Review Criteria
10/18/2010 Ranking • Primary reason for denial – your proposed program, compared to other grants received in this cycle, has been ranked lower than the grants we have chosen to fund fund. This decision considers both educational outcomes and costs from the perspective of improving patient care. Plea
Slide 14: Previous Outcomes; Summary
10/18/2010 Previous outcomes • Primary reason for denial – your organization has not demonstrated a consistent pattern of p p providingg educational outcomes as described in the original grant requests. Such outcomes information should be submitted as part of the post-activity reconciliation process
Slide 15: CME Best Practice: Using Performance Improvement Metric Tools
10/18/2010 CME Best Practice: Using Performance Improvement Metric Tools Susan K. Keiser, MSN, RN Education Specialist, CME Northern Michigan Regional Hospital, Petoskey, Ml 7 Northern 7 Michigan 15
Slide 16: Integrated Systems Approach
10/18/2010 Integrated Systems Approach 4, Partnership of CME and PI 4, Presence on key committees/teams 4, Common tools 4, Shifting focus from capital intensive labor to process evaluation and improvement 4, Sustainable changes in practice-system-wide Quality Data 4, Regulatory Agency Requirements 4
Slide 17: Needs Assessment
Needs Assessment 4, Occurrence report trends 4, Physician/Colleague opinion surveys 4, Patient Satisfaction Surveys 4r Peer Review education requests 4r Unit/Program/Team Scorecards CPHQ Scorecard i cluded) a 1. | CPHO participant al developuse PiTools | Strategy | Perspective Colleague CH Value oua
Slide 18: Keystone ED Project Scorecard
Keystone ED Proj ect Scorecard Target = Total number of charts per quarter; Actual] a =Total number of | pri"e"ciel | 98.9% | 90.0% complete charts per pe quarter . Price + Efficiency Financial f Way Variance 6 Effci peancial, | $9,479 | $0 $26,918 .C Key Drivers: ihe i, PRC 90th Percentile is Custo
Slide 19: Tips for Engagement
Tips for Engagement 4, Committee/team membership 4, Communicate/collaborate with PI Staff 4, Use a common language 4, Use common tools Resources ry www.accme.org r WwwW.ama-assn.org/amalpub/category/4837.html y www.cms.hhs.gov/PQRI y www.qualitymeasures.ahrq.gov ry www.qualitynet.org y www.patientsa
Slide 20: How can we help?
10/18/2010 Until Next Time 1. 2010 goal to improve dialogue with the CE community • Upcoming webinars: • November 5th – Invitations to be sent out the week of October 18th • 11AM EST: Dec 3 2. You can always contact us if you have any questions related to a grant request once a decision has been mad